negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)
Namespace: biological_process
Definition: Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C-activating G protein-coupled receptor signaling pathway.
Synonyms: down regulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger; down regulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating); down regulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating); down regulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger; down regulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); down regulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating); down regulation of phospholipase C-activating dopamine receptor signaling pathway; down regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; down regulation of PLC-activating GPCR signaling pathway; down-regulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger; down-regulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating); down-regulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating); down-regulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger; down-regulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); down-regulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating); down-regulation of phospholipase C-activating dopamine receptor signaling pathway; down-regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; down-regulation of PLC-activating GPCR signaling pathway; downregulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger; downregulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating); downregulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating); downregulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger; downregulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); downregulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating); downregulation of phospholipase C-activating dopamine receptor signaling pathway; downregulation of phospholipase C-activating G-protein coupled receptor signaling pathway; downregulation of PLC-activating GPCR signaling pathway; inhibition of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger; inhibition of G protein signaling, coupled to IP3 second messenger (phospholipase C activating); inhibition of G protein signalling, coupled to IP3 second messenger (phospholipase C activating); inhibition of G-protein coupled receptor signaling pathway coupled to IP3 second messenger; inhibition of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); inhibition of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating); inhibition of phospholipase C-activating dopamine receptor signaling pathway; inhibition of phospholipase C-activating G-protein coupled receptor signaling pathway; inhibition of PLC-activating GPCR signaling pathway; negative regulation of activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger; negative regulation of G protein signaling, coupled to IP3 second messenger (phospholipase C activating); negative regulation of G protein signalling, coupled to IP3 second messenger (phospholipase C activating); negative regulation of G-protein coupled receptor signaling pathway coupled to IP3 second messenger; negative regulation of G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); negative regulation of G-protein signalling, coupled to IP3 second messenger (phospholipase C activating); negative regulation of phospholipase C-activating dopamine receptor signaling pathway; negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; negative regulation of PLC-activating GPCR signaling pathway